Market Research Assistance

On the Web
Refine Result

By Date

Last Month
Last 3 Months
Last 6 Months
Last Year
Last 2 Years

By Price

< $1000
$1000-$2500
$2501-$4000
$4001-$5500
$5501-$7500
$7501-$9000
>$9000

Gastrointestinal therapeutics Market Research Reports

Titlepublishedprice

United States Esomeprazole Market Report 2017

By QYResearch Group
"...... covering - AstraZeneca AB - Sandoz - Actavis - Teva - Mylan - KernPharm - Garmish Pharmaceuticals - Sanofi - Mepha - Saval Pharmaceutical - Stada - Blaskov - C......"
13-Jan-2017$3800

Global Esomeprazole Sales Market Report 2017

By QYResearch Group
"...... untries, with sales, price, revenue and market share for each player in these regions, covering - AstraZeneca AB - Sandoz - Actavis - Teva - Mylan - KernPharm - Garmish Pharmaceuticals - Sanofi......"
12-Jan-2017$4000

China Esomeprazole Market Research Report 2017

By QYResearch Group
"...... urer, covering - AstraZeneca AB - Sandoz - Actavis - Teva - Mylan - KernPharm - Garmish Pharmaceuticals - Sanofi - Mepha - Saval Pharmaceutical - Stada - Blaskov......"
11-Jan-2017$3200

Duodenal Ulcer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

By Delve Insight
"...... s to understand the market and pipeline status of the drugs around the Duodenal Ulcer to explore the generic development opportunities, licensing opportunities and to gain competitive advantage on designing pipeline startegies. The DelveInsight's Rep......"
01-Jan-2017$2000

Mezavant Xl -Drug Insights, 2017

By Delve Insight
"...... d also provides the Mezavant Xl sales performance during the historical period and forecast period to 2018. DelveInsight's Report also covers the detailed clinical assessment of Mezavant Xl, patents information and exclusivity data, route of synthesi......"
01-Jan-2017$1000

Mucosta -Drug Insights, 2017

By Delve Insight
"...... des the Mucosta sales performance during the historical period and forecast period to 2018. DelveInsight's Report also covers the detailed clinical assessment of Mucosta, patents information and exclusivity data, route of synthesis, competitive lands......"
01-Jan-2017$1000

Gastric Ulcers-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

By Delve Insight
"...... s to understand the market and pipeline status of the drugs around the Gastric Ulcers to explore the generic development opportunities, licensing opportunities and to gain competitive advantage on designing pipeline startegies. The DelveInsight's Rep......"
01-Jan-2017$2000

Peptic Ulcer  - Epidemiology Forecast To 2023

By Delve Insight
"...... dent cases segmented by age, sex and subpopulations. The Report also discusses the prevailing risk factors, disease burden with special emphasis on the unmet medical need associated with the Peptic Ulcer . The report is built using data and informati......"
01-Jan-2017$2750

Irritable Bowel Syndrome-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

By Delve Insight
"...... el Syndrome Report is to understand the market and pipeline status of the drugs around the Irritable Bowel Syndrome to explore the generic development opportunities, licensing opportunities and to gain competitive advantage on designing pipeline star......"
01-Jan-2017$2000

Ulcerative Colitis-API Insights, 2017

By Delve Insight
"...... market as generic drugs occupy the market. India and China produce a large percentage of a majority of the APIs and intermediates produced in the world currently. The USFDA and EMA have strict guidelines for API manufacturing 'Process......"
01-Jan-2017$1250

Avail upto 50% Discount on below Publisher Reports.